Actualités

Cryptocurrency treasury firm Metaplanet has denied selling $320 million U.S. worth of its Bitcoin (CRYPTO: $BT...

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the ‘TCW Concentrated Large Cap Growth Fund.’ A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve leadership transition were the significant events. All major indices ended higher, […]

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Intel has staged one of the most dramatic stock revivals in recent memory, but two unresolved catalysts will either confirm the turnaround as real or expose this year's triple-digit rally as a trade that ran far ahead of the fundamentals.

Here is how Halozyme Therapeutics (HALO) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

Here is how Paysign, Inc. (PAYS) and Sezzle Inc. (SEZL) have performed compared to their sector so far this year.

IREN Limited (NASDAQ:IREN) shares gained 6% on Thursday morning after the company completed delivery of its Horizon 1 AI infrastructure deployment to Microsoft and secured NVIDIA Exemplar Cloud status for its GB300 NVL72 installation. The milestones mark further progress in IREN’s large-scale AI Cloud expansion strategy and its five-year agreement with Microsoft.

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the ‘TCW Concentrated Large Cap Growth Fund.’ A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve leadership transition were the significant events. All major indices ended higher, […]

Vantage Data Centers (AMEX:VNTG) and Nebius (NASDAQ:NBIS) have agreed to deploy Nvidia-powered artificial intelligence infrastructure at Vantage’s CWL1 data centre campus in Newport, Wales, expanding the region’s role in the UK’s growing AI infrastructure market. The agreement represents the first announced commercial capacity commitment within the South Wales AI Growth Zone.

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the ‘TCW Concentrated Large Cap Growth Fund.’ A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve leadership transition were the significant events. All major indices ended higher, […]

The company has discussed a nine-figure budget for a variable compensation plan that would pay publishers when their content is used

Aug 13 (Reuters) - Wall Street's main indexes opened higher on Thursday as crude oil prices fell, improving risk appetite, while investors parsed a softer-than-expected producer price inflation

A California biotech just raised $350 million promising to out-perform opioids without the addiction risk, and its auditors were still warning about survival just months ago. Here is what the science and the filings actually show.

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Commercial progress is finally becoming tangible.

Blue Energy and GE Vernova Hitachi Nuclear Energy (NYSE:GEV) have agreed to advance development of a proposed 2. 5-gigawatt gas-and-nuclear power facility in Victoria, Texas, moving the project into its next phase of engineering, licensing and safety work.

The stock market cleared both of this week’s inflation reports, but gains were fairly muted. The Nasdaq Composite was 0.2%. The big three indexes were mixed on Wednesday after the July consumer price index matched expectations.

Texas Instruments' surging free cash flow, lower capital spending and stronger growth boost its capacity for dividends and share buybacks.

The most profitable corner of the technology market pays income investors a pittance -- and each of these four companies has a different reason.

Microsoft accepted the first of four liquid-cooled deployments under IREN’s $9.7 billion contract, while NVIDIA awarded the GB300 system Exemplar Cloud status after testing.

Arm just posted its third straight year of 20-plus percent revenue growth with the AI era's dominant compute platform, yet the stock sits 33% below its recent peak and Wall Street's upside calls look surprisingly timid given what the AGI CPU pipeline could actually deliver.

According to the average brokerage recommendation (ABR), one should invest in SLB (SLB). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

SoundHound AI is betting that its acquisition-driven growth formula can turn LivePerson into another major source of customers and revenue.

The average brokerage recommendation (ABR) for Silicon Motion (SIMO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

According to the average brokerage recommendation (ABR), one should invest in RTX (RTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

From a sidelined breakfast menu to a fizzling marketing strategy, Wendy’s’ downward trajectory has cost the chain its No. 2 spot in the burger market.

Record Amtagvi revenue and gross margins signal strong commercial momentum in cell therapy.

BWXT expands its commercial nuclear portfolio through nuclear medicine, isotope production and radiopharmaceutical capabilities.